Literature DB >> 2063767

Patients with a high defibrillation threshold: clinical characteristics, management, and outcome.

S L Pinski1, G Vanerio, L W Castle, V A Morant, T W Simmons, R G Trohman, B L Wilcoff, J D Maloney.   

Abstract

Of 125 patients prepared to receive implantable cardioverter-defibrillators (ICDs) with the patch-patch configuration of the difibrillating electrodes, 23 (18%) had high (greater than or equal to 25 joules) defibrillation thresholds (DFTs). These patients had lower left ventricular ejection fractions (27 +/- 12 vs 34 +/- 13; p less than 0.03) and a higher incidence of previous heart surgery (47% vs 19%; p less than 0.01) than patients with normal DFTs but did not differ in age, type of heart disease, incidence of concomitant heart surgery, or use of antiarrhythmic medication. Defibrillators were implanted in 18 of these 23 patients, 12 during the initial surgery and six after repeat DFT testing 2 weeks later. After 22 +/- 11 months of follow-up, four patients with ICDs died (two suddenly, and two of nonsudden cardiac causes). Two patients without ICDs died of nonsudden cardiac causes. Appropriate shocks were received by five patients (29%) including both who died suddenly later. A high DFT may be more common than previously stated. It is associated with poor ventricular function and previous heart surgery. Repeated DFT testing may be useful in some patients. A high DFT does not preclude successful ICD shocks, but other therapies may provide better results.

Entities:  

Mesh:

Year:  1991        PMID: 2063767     DOI: 10.1016/0002-8703(91)90763-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  [Influence of amiodarone on defibrillation threshold and perioperative complications in patients with implantable cardioverter-defibrillator with transvenous electrodes and biphasic shocks].

Authors:  W Grimm; V Menz; J Hoffmann; U Timmann; R Moosdorf; B Maisch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-06

2.  Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation.

Authors:  Zhongwei Cheng; Mintu Turakhia; Ronald Lo; Anurag Gupta; Paul C Zei; Henry H Hsia; Amin Al-Ahmad; Paul J Wang
Journal:  J Interv Card Electrophysiol       Date:  2012-03-06       Impact factor: 1.900

3.  Experience of cardioverter-defibrillators inserted without thoracotomy: evaluation of transvenously inserted intracardiac leads alone or with a subcutaneous axillary patch.

Authors:  L Jordaens; J W Trouerbach; P Vertongen; L Herregods; J Poelaert; G Van Nooten
Journal:  Br Heart J       Date:  1993-01

4.  A randomized comparison of defibrillation thresholds in the right ventricular outflow tract versus right ventricular apex.

Authors:  Michael Mollerus; Margaret Lipinski; Thomas Munger
Journal:  J Interv Card Electrophysiol       Date:  2008-05-10       Impact factor: 1.900

5.  Does defibrillation threshold increase as left ventricular ejection fraction decreases?

Authors:  Jesus E Val-Mejias; Ashish Oza
Journal:  Europace       Date:  2010-01-03       Impact factor: 5.214

6.  Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?

Authors:  Luis A Pires
Journal:  Indian Pacing Electrophysiol J       Date:  2007-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.